SynapSense Technologies

SynapSense Technologies is a neurotechnology company focused on developing objective neural biomarkers for pain, headquartered in Austin, Texas. The company utilizes non-invasive electroencephalography (EEG) to capture pain-related cortical activity and translate it into quantitative metrics for continuous, objective pain measurement. SynapSense aims to address the subjectivity of pain assessment by leveraging real-time EEG and machine learning to quantify pain through measurable neural signatures. This approach provides interpretable insights that can assist clinicians, researchers, and patients. The company’s work integrates neuroscience, clinical research, and artificial intelligence, with the goal of improving pain assessment, enabling precise treatment decisions, and advancing research in chronic pain, neurology, and precision medicine.